Full Text View
Tabular View
No Study Results Posted
Related Studies
CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients (CHAMPION)
This study is currently recruiting participants.
Study NCT00531661   Information provided by CardioMEMS
First Received: September 18, 2007   Last Updated: December 5, 2008   History of Changes

September 18, 2007
December 5, 2008
August 2007
October 2010   (final data collection date for primary outcome measure)
The primary hypothesis is that the TREATMENT group will have a significantly lower rate of HF-related hospitalizations than the CONTROL group. [ Time Frame: 6 months ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT00531661 on ClinicalTrials.gov Archive Site
 
 
 
CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients
CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients

This is a prospective, multi-center, randomized, single-blind clinical trial conducted in the United States (US). The objective of the study is to evaluate the safety and efficacy of the HF Pressure Measurement System in reducing heart failure (HF) related hospitalizations in a subset of subjects suffering from HF.

 
 
Interventional
Diagnostic, Randomized, Single Blind (Subject), Placebo Control, Parallel Assignment, Safety/Efficacy Study
Heart Failure, Congestive
Device: HF Pressure Measurement System
  • Active Comparator: TREATMENT group: standard of care HF management plus HF management based upon hemodynamic information obtained from the HF Pressure Measurement System
  • Sham Comparator: CONTROL group: standard of care HF management
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
550
August 2011
October 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

Contact sponsor for details.

Exclusion Criteria:

Contact sponsor for details.

Both
18 Years and older
No
Contact: Bradley Jeffries, MD 678-651-2339
United States
 
NCT00531661
Susan Neville, Clinical Project Manager, CardioMEMS, Inc.
CM-06-04
CardioMEMS
 
Principal Investigator: Phillip Adamson, MD, FACC Oklahoma Heart Hospital
Principal Investigator: William T Abraham, MD, FACC The Ohio State University Medical Center
CardioMEMS
December 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP